Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1964 1
1970 1
1979 1
1981 2
1983 3
1988 1
1989 1
1990 1
1991 1
1992 1
1996 5
1997 3
1999 4
2000 5
2001 3
2002 5
2003 7
2004 7
2005 8
2006 6
2007 6
2008 4
2009 3
2010 7
2011 6
2012 8
2013 7
2014 7
2015 5
2016 12
2017 7
2018 6
2019 9
2020 21
2021 33
2022 37
2023 32
2024 13

Text availability

Article attribute

Article type

Publication date

Search Results

254 results

Results by year

Filters applied: . Clear all
The following term was ignored: %
The following term was not found in PubMed: 20Shimadera
Page 1
Musical and poetic creativity and epilepsy.
Hesdorffer DC, Trimble M. Hesdorffer DC, et al. Epilepsy Behav. 2016 Apr;57(Pt B):234-7. doi: 10.1016/j.yebeh.2015.12.042. Epub 2016 Feb 16. Epilepsy Behav. 2016. PMID: 26898116 Review.
The only composer with epilepsy that we could find was the contemporary composer, Hikari Oe, who has autism and developed epilepsy at age 15years. In his childhood years, his mother found that he had an ability to identify bird sound and keys of songs and began teaching hi …
The only composer with epilepsy that we could find was the contemporary composer, Hikari Oe, who has autism and developed epilepsy at …
PCSK9 Inhibition During the Inflammatory Stage of SARS-CoV-2 Infection.
Navarese EP, Podhajski P, Gurbel PA, Grzelakowska K, Ruscio E, Tantry U, Magielski P, Kubica A, Niezgoda P, Adamski P, Junik R, Przybylski G, Pilaczyńska-Cemel M, Rupji M, Specchia G, Pinkas J, Gajda R, Gorog DA, Andreotti F, Kubica J. Navarese EP, et al. J Am Coll Cardiol. 2023 Jan 24;81(3):224-234. doi: 10.1016/j.jacc.2022.10.030. J Am Coll Cardiol. 2023. PMID: 36653090 Free PMC article. Clinical Trial.
DNA-repair enzymes.
Vassylyev DG, Morikawa K. Vassylyev DG, et al. Curr Opin Struct Biol. 1997 Feb;7(1):103-9. doi: 10.1016/s0959-440x(97)80013-9. Curr Opin Struct Biol. 1997. PMID: 9032058 Review.
Long-term efficacy and safety of certolizumab pegol in Japanese rheumatoid arthritis patients who could not receive methotrexate: 52-week results from an open-label extension of the HIKARI study.
Tanaka Y, Yamamoto K, Takeuchi T, Yamanaka H, Ishiguro N, Eguchi K, Watanabe A, Origasa H, Shoji T, Miyasaka N, Koike T. Tanaka Y, et al. Mod Rheumatol. 2014 Sep;24(5):725-33. doi: 10.3109/14397595.2013.865822. Epub 2013 Dec 29. Mod Rheumatol. 2014. PMID: 24372225 Clinical Trial.
OBJECTIVES: To evaluate the long-term efficacy and safety of certolizumab pegol (CZP) treatment and to assess the efficacy of two CZP maintenance dosing schedules in Japanese rheumatoid arthritis (RA) patients who could not receive methotrexate (MTX). METHODS: HIKARI doubl …
OBJECTIVES: To evaluate the long-term efficacy and safety of certolizumab pegol (CZP) treatment and to assess the efficacy of two CZP mainte …
Efficacy and safety of certolizumab pegol without methotrexate co-administration in Japanese patients with active rheumatoid arthritis: the HIKARI randomized, placebo-controlled trial.
Yamamoto K, Takeuchi T, Yamanaka H, Ishiguro N, Tanaka Y, Eguchi K, Watanabe A, Origasa H, Iwai K, Sakamaki Y, van der Heijde D, Miyasaka N, Koike T. Yamamoto K, et al. Mod Rheumatol. 2014 Jul;24(4):552-60. doi: 10.3109/14397595.2013.843764. Epub 2013 Nov 1. Mod Rheumatol. 2014. PMID: 24981319 Clinical Trial.
Post-hoc analysis showing better clinical response with the loading dose of certolizumab pegol in Japanese patients with active rheumatoid arthritis.
Takeuchi T, Yamamoto K, Yamanaka H, Ishiguro N, Tanaka Y, Eguchi K, Watanabe A, Origasa H, Kobayashi M, Shoji T, Togo O, Miyasaka N, Koike T. Takeuchi T, et al. Mod Rheumatol. 2016 Jul;26(4):473-80. doi: 10.3109/14397595.2015.1109182. Epub 2015 Dec 14. Mod Rheumatol. 2016. PMID: 26472043 Free PMC article. Clinical Trial.
METHODS: Data from the double-blind trials (DBT) J-RAPID and HIKARI, and their open-label extension (OLE) studies, were used. Patients randomized to CZP 200 mg every 2 weeks (Q2W) groups starting with LD (400 mg Weeks 0/2/4; LD group; J-RAPID: n = 82, HIKARI: n = 11 …
METHODS: Data from the double-blind trials (DBT) J-RAPID and HIKARI, and their open-label extension (OLE) studies, were used. Patient …
254 results